Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sleep apnea
Biotech
Shionogi pays Apnimed $100M for sleep disorder joint venture
Shionogi is taking full control of its sleep disorder joint venture, agreeing to pay Apnimed $100 million upfront for its partner’s stake.
Nick Paul Taylor
Mar 24, 2026 9:20am
Beacon Biosignals aglow with $86M neurodiagnostic fundraising
Nov 17, 2025 9:25am
Apnimed's sleep apnea star goes 2 for 2 in phase 3
Jul 23, 2025 6:00am
Apnimed eyes FDA sleep apnea submission after positive results
May 19, 2025 6:00am
FDA clears vibrating pad to nudge breathing in preterm newborns
Apr 8, 2025 11:00am
Resmed debuts wearable, at-home sleep apnea test
Apr 4, 2025 12:00pm
